Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

BDX – Becton, Dickinson and Company

Becton, Dickinson and Company
BDX
$205.08
Name : Becton, Dickinson and Company
Sector : Healthcare
Industry: Medical Instruments & Supplies
Mark. Cap: $58,885,648,384.00
EPSttm : 5.95
finviz dynamic chart for BDX
Becton, Dickinson and Company
$205.08
0.31%
$0.63

Float Short %

1.32

Margin Of Safety %

19

Put/Call OI Ratio

0.38959482894529

EPS Next Q Diff

0.14

EPS Last/This Y

8.49

EPS This/Next Y

1.21

Price

205.08

Target Price

267.67

Analyst Recom

1.68

Performance Q

-15.76

Relative Volume

0.76

Beta

0.33

Ticker: BDX




22 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-03-27BDX228.690.390.0241533
2025-03-28BDX227.480.340.2345800
2025-03-31BDX229.070.330.8546441
2025-04-01BDX226.010.330.6646472
2025-04-02BDX226.40.350.2649829
2025-04-03BDX221.590.351.4150557
2025-04-04BDX207.480.360.6951599
2025-04-07BDX205.190.371.0853158
2025-04-08BDX200.870.370.2953470
2025-04-09BDX209.390.380.3253726
2025-04-10BDX199.170.370.0753333
2025-04-11BDX201.720.350.2855669
2025-04-14BDX205.720.354.6355674
2025-04-15BDX202.020.330.1755071
2025-04-16BDX200.370.332.6055172
2025-04-17BDX198.750.320.1955016
2025-04-18BDX198.710.320.2055016
2025-04-21BDX196.610.380.3243152
2025-04-22BDX199.870.390.4043153
2025-04-23BDX202.320.394.1643371
2025-04-24BDX204.370.384.1243822
2025-04-25BDX205.080.389594828945290.9915966386554644071
DateSymbolLastP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-03-27BDX228.663.4428.714.42
2025-03-28BDX227.503.4409.714.42
2025-03-31BDX229.023.5437.414.42
2025-04-01BDX226.043.5391.514.42
2025-04-02BDX226.423.5425.914.42
2025-04-03BDX221.603.5372.914.42
2025-04-04BDX207.443.5275.414.42
2025-04-07BDX205.143.5398.014.42
2025-04-08BDX200.833.5375.214.37
2025-04-09BDX209.593.5519.814.37
2025-04-10BDX199.173.5311.814.37
2025-04-11BDX201.653.5450.414.37
2025-04-14BDX205.713.5465.814.37
2025-04-15BDX202.043.5381.714.37
2025-04-16BDX200.323.5402.814.37
2025-04-17BDX198.713.5403.014.37
2025-04-18BDX198.713.5422.014.37
2025-04-21BDX196.683.5399.114.37
2025-04-22BDX199.883.5459.114.37
2025-04-23BDX202.323.5449.314.37
2025-04-24BDX204.353.5444.614.37
2025-04-25BDX205.083.5428.914.37
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-03-27BDX-2.631.911.00
2025-03-28BDX-2.631.911.00
2025-03-31BDX-2.631.301.00
2025-04-01BDX-2.631.301.00
2025-04-02BDX-2.631.301.00
2025-04-03BDX-2.631.301.00
2025-04-04BDX-2.631.301.00
2025-04-07BDX-2.631.291.00
2025-04-08BDX-2.631.291.00
2025-04-09BDX-2.631.291.00
2025-04-10BDX-2.711.291.32
2025-04-11BDX-2.711.291.32
2025-04-14BDX-2.711.331.32
2025-04-15BDX-2.711.331.32
2025-04-16BDX-2.711.331.32
2025-04-17BDX-2.711.331.32
2025-04-18BDX-2.711.331.32
2025-04-21BDX-2.711.301.32
2025-04-22BDX-2.711.301.32
2025-04-23BDX-2.711.301.32
2025-04-24BDX-2.711.301.32
2025-04-25BDX-2.711.301.32
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

3.43

Avg. EPS Est. Current Quarter

3.28

Avg. EPS Est. Next Quarter

3.57

Insider Transactions

-2.71

Institutional Transactions

1.3

Beta

0.33

Average Sales Estimate Current Quarter

5352

Average Sales Estimate Next Quarter

5501

Fair Value

244.6

Quality Score

73

Growth Score

83

Sentiment Score

94

Actual DrawDown %

28.6

Max Drawdown 5-Year %

-30.7

Target Price

267.67

P/E

34.07

Forward P/E

13.1

PEG

3.78

P/S

2.85

P/B

2.34

P/Free Cash Flow

20.06

EPS

6.02

Average EPS Est. Cur. Y​

14.37

EPS Next Y. (Est.)

15.59

Target Price Estimates Raised

Target Price Estimates Lowered

1

Profit Margin

8.47

Relative Volume

0.76

Return on Equity vs Sector %

-14.3

Return on Equity vs Industry %

-1.8

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.04

EBIT Estimation

428.9
Becton, Dickinson and Company
Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 70000
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation systems, and medication inventory optimization and tracking systems; hemodynamic monitoring systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
stock quote shares BDX – Becton, Dickinson and Company Stock Price stock today
news today BDX – Becton, Dickinson and Company stock forecast ,stock prediction 2023 2024 2025
marketwatch BDX – Becton, Dickinson and Company yahoo finance google finance
stock history BDX – Becton, Dickinson and Company invest stock market
stock prices BDX premarket after hours
ticker BDX fair value insiders trading